Interoperable Automated Glycemic Controller
Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.
OpenFDA device adverse-event casebook.
FDA Class II (moderate risk, special controls required), regulated under 21 CFR §862.1356 (Clinical Chemistry panel).
FDA MAUDE casebook
openFDA event book Interoperable Automated Glycemic Controller LIGHT-BOOK · MAUDE
#407 of 1000 · 3,009 reports · 2020–2026
- BOOK 3,009 reports
- RANK #407 of 1000
- DEATH 3 death-typed
- INJ 899 injury-typed
- MALF 2,104 malfunction
- SPAN 2020–2026
- PEAK 2026: 2,959
- PHOTO Prosthesis
Nearest event-volume peer: Prosthesis, Tracheal, Expandable (0 report gap)
Interoperable Automated Glycemic Controller sits #407 of 1000 among tracked device types with 3,009 MAUDE reports spanning 2020–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →
Malfunction reports run above the device-type norm
Interoperable Automated Glycemic Controller carries 69.9% MALFUNCTION-coded reports, 5.1pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.
- DEATH 0.1% corpus 1.5% · below corpus mean (-1.4 pp)
- INJ 29.9% corpus 30.3% · near corpus mean (-0.4 pp)
- MALF 69.9% corpus 64.8% · above corpus mean (+5.1 pp)
Lead product-problem code Adverse Event Without Identified Device or Use Problem is 17% of coded problems · Lead manufacturer MEDTRONIC PUERTO RICO OPERATIONS CO. accounts for 89% of manufacturer-tagged reports · Top event location is 100% of location-tagged rows .
Interoperable Automated Glycemic Controller in the event-volume neighbourhood
FDA MAUDE report totals among this device type and nearest nationwide peers
- Prosthesis
Prosthesis, Elbow, Constrained, Cemented
3,057 reports
- Interoperable… (this)
Interoperable Automated Glycemic Controller
3,009 reports
- Prosthesis
Prosthesis, Tracheal, Expandable
3,009 reports
- Latex Patient…
Latex Patient Examination Glove
2,992 reports
- Medical Devic…
Medical Device Data System
2,981 reports
- System
System, Photopheresis, Extracorporeal
2,966 reports
What this shows Interoperable Automated Glycemic Controller carries 3,009 MAUDE reports, ranked #407 of 1000.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Top Product Problems
Yearly Trend
Reports fell to 3 in 2025, down from an average of 21 in the two years before.
Related Entities for Interoperable Automated Glycemic Controller
Top Manufacturers
Event Locations
Compare MEDTRONIC PUERTO RICO OPERATIONS CO. vs Medtronic Puerto Rico Operations Co. →
Nationwide devices with a comparable volume-and-death footprint
Two openFDA-derived peer sets for Interoperable Automated Glycemic Controller: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.
Similar report volume
Nearest other device types by FDA MAUDE report count (3,009 here).
Similar death-typed counts
Nearest other device types by death-typed report count (3 here), distinct from the volume row.
Read our methodology - how this data is sourced, computed, and verified.
Disclaimer: MAUDE figures for Interoperable Automated Glycemic Controller are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.
Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Interoperable Automated Glycemic Controller; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.